Investing
European shares end week higher as Pfizer pill lifts travel stocks
Published by Jessica Weisman-Pitts
Posted on November 5, 2021
2 min readLast updated: January 28, 2026
Global Banking & Finance Review®
Company
Published by Jessica Weisman-Pitts
Posted on November 5, 2021
2 min readLast updated: January 28, 2026
European shares rose, driven by travel stocks after Pfizer's COVID-19 pill update, with STOXX 600 gaining for the fifth week.
By Shreyashi Sanyal
(Reuters) -European equities wrapped up another week of gains on Friday, led by advances in travel stocks after a positive update from U.S. drugmaker Pfizer on its pill for COVID-19 and amid persistent optimism about earnings season.
The pan-European STOXX 600 ended flat, but clocked 1.7% in weekly gains, its fifth consecutive week in the green.
European travel stocks jumped 1.4% as investors across the globe cheered Pfizer Inc’s trial of an experimental antiviral pill for COVID-19, which was shown to cut risk of developing severe disease by 89%.
The news lifted shares of Swiss duty free retailer Dufry by 10.1%, to its best day since November 9, 2020, while also pushing down shares of AstraZeneca.
“Today’s news out of the U.S. that Pfizer has developed a COVID-19 pill, which is 89% effective in preventing hospitalisation, may well be weighing on the AstraZeneca share price a touch, but it has pretty much turbo-charged the airlines and hospitality sector,” said Michael Hewson, chief market analyst at CMC Markets.
Dovish moves by the U.S. Federal Reserve and the Bank of England, and similar comments from the European Central Bank chief have helped sentiment this week.
Data from the U.S. Labor Department showed employment increased more than expected in October as the headwinds from a surge in COVID-19 infections over the summer subsided, also supporting the day’s upbeat mood.
On Friday, France’s benchmark CAC 40 index breached the 7,000 points barrier for the first time ever, and was up 0.8%.
The blue-chip index was led by gains in Kering, Hermes and L’Oreal.
Germany’s DAX reversed early declines to scale fresh peaks, as investors shrugged off disappointing industrial output data in Europe’s biggest economy.
Gains in the STOXX 600 were led by Allegro, which surged 10.6% after the Polish e-commerce group agreed to buy Czech online retailer Mall Group for 881 million euros.
Spain’s CaixaBank also rose 1.6% after saying it had sold its entire 9.92% stake in Austrian bank Erste Group for 1.503 billion euros. Erste added 5%.
A rebound in London-listed banks, which dropped after the Bank of England’s move on Thursday to hold rates, saw London’s FTSE 100 gain 0.3%.
(Reporting by Anisha Sircar, Susan Mathew and Shreyashi Sanyal in Bengaluru; Editing by Shounak Dasgupta, William Maclean)
The article discusses the rise in European shares, particularly travel stocks, following Pfizer's COVID-19 pill update.
Pfizer's COVID-19 pill, showing 89% efficacy, boosted travel stocks and overall market optimism.
The STOXX 600, CAC 40, and DAX indices showed notable gains, with CAC 40 breaching 7,000 points.
Explore more articles in the Investing category
